APA (7th ed.) Citation

Yang, N., Zhang, C., Zhang, Y., Fan, Y., Zhang, J., Lin, X., . . . He, Z. (2024). CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia. Journal of Translational Medicine, 22, 1. https://doi.org/10.1186/s12967-024-04990-6

Chicago Style (17th ed.) Citation

Yang, Na, et al. "CD19/CD20 Dual-targeted Chimeric Antigen Receptor-engineered Natural Killer Cells Exhibit Improved Cytotoxicity Against Acute Lymphoblastic Leukemia." Journal of Translational Medicine 22 (2024): 1. https://doi.org/10.1186/s12967-024-04990-6.

MLA (9th ed.) Citation

Yang, Na, et al. "CD19/CD20 Dual-targeted Chimeric Antigen Receptor-engineered Natural Killer Cells Exhibit Improved Cytotoxicity Against Acute Lymphoblastic Leukemia." Journal of Translational Medicine, vol. 22, 2024, p. 1, https://doi.org/10.1186/s12967-024-04990-6.